Navigation Links
Parkinson's Drug May Fight Cancer
Date:3/15/2008

Dopamine prevents tumors from gaining a blood supply, studies suggest

SATURDAY, March 15 (HealthDay News) -- The drug dopamine -- currently used to treat patients with conditions such as Parkinson's disease, pituitary tumors and heart attack -- may also prove effective in cancer patients, a Mayo Clinic study finds.

In laboratory and mouse tests, researchers found dopamine can help prevent the development of new blood vessels, something that would slow the progression of cancer. The findings were published in the online edition of the Journal of Clinical Investigation.

"Researchers can now test this concept in solid tumors where angiogenesis (formation of new blood vessels) plays a critical role in the growth and progression of these cancers," Dr. Sujit Basu, a Mayo Clinic oncologist, said in a prepared statement.

Specifically, Basu and colleagues found that dopamine prevents the transfer of endothelial progenitor cells (which help form new blood vessels) from bone marrow into the circulatory system. The drug does this by binding to a specific receptor on the surface of the progenitor cells. This suppresses the activity of an enzyme (MMP-9) that enables the progenitor cells to move out of bone marrow.

In their experiments, the researchers found that dopamine significantly decreased movement of progenitor cells from bone marrow and decreased MMP-9 expression.

"Sometimes new drugs may not be the answer. We looked instead at a novel use for an established product, and have found very promising results," Basu said.

Natural dopamine is a neurotransmitter in the brain that regulates movement and affects behavior. The drug is a synthetic form of the natural brain chemical.

"This is the first time it has been shown that an important neurotransmitter like dopamine is regulating the mobilization of these progenitor cells from the bone marrow. This is very important, and represents why these findings are so unique," Basu said.

More information

The U.S. National Cancer Institute has more about angiogenesis.



-- Robert Preidt



SOURCE: Mayo Clinic, news release, March 13, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Preclinical study suggests organ-transplant drug may aid in lupus fight
2. Computers help chemists fight emerging infections
3. Study shines more light on benefit of vitamin D in fighting cancer
4. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
5. HIV Drug Might Fight Cancer
6. ADA Challenges Marylanders to Step Out to Fight Diabetes Epidemic
7. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
8. Drug, Pacemaker Fight Irregular Heartbeat
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. The fight against colorectal cancer
11. Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Parkinson's Drug May Fight Cancer
(Date:2/24/2017)... ... 24, 2017 , ... HealthPostures, expert standing desk solution designer, ... built into the home office sit stand solution are bold colors, a new ... the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' online ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official release of ... in Cannes (France), XO Private has initiated a second print-run of its lavish luxury ... a metre across when open, weighs in at more than six kilos, retails at ...
(Date:2/24/2017)... ... , ... An in-depth computational analysis of genetic variants implicated in both schizophrenia ... that may explain why susceptibility to one of the disorders could place individuals at ... in the journal npj Schizophrenia. , “There is a wealth of genomic data ...
(Date:2/24/2017)... ... ... The Smart Machine Age is here, and it’s disrupting everything. Not only could it ... the United States may be taken over by technology in the next five to ... over colleagues is drawing to a close. Success will belong to those who can ...
(Date:2/24/2017)... ... February 24, 2017 , ... With ... is so critically important that we all are aware of our options and ... is proud to announce the launch of its newest edition of "Vision and ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis ... the global Urinary Incontinence market. The research answers the following ... marketed for Urinary Incontinence and their clinical attributes? How are they ...
(Date:2/23/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device ... for the urology market, will release financial results for ... 2016 before the market open on Thursday, March 9, ... conference call and webcast to discuss its financial results ... 11:00 a.m. Eastern Time (10:00 a.m. Central Time). ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis ... the global Oesophageal Cancer market. The research answers the ... drugs marketed for Oesophageal Cancer and their clinical attributes? How are ...
Breaking Medicine Technology: